# EDGAR Filing Document

**Accession Number:** 0001756770
**File Stem:** 0001104659-23-036650
**Filing Date:** 2023-3
**Character Count:** 7197
**Document Hash:** 86e865b1ebd3b8575d23b73be163980b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-036650.hdr.sgml**: 20230324

**ACCESSION NUMBER**: 0001104659-23-036650

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230324

**FILED AS OF DATE**: 20230324

**DATE AS OF CHANGE**: 20230324

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Curaleaf Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001756770
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-249081
- **FILM NUMBER:** 23760315

**BUSINESS ADDRESS:**
- **STREET 1:** 610 - 700 WEST PENDER STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 1G8
- **BUSINESS PHONE:** 604-218-4766

**MAIL ADDRESS:**
- **STREET 1:** 610 - 700 WEST PENDER STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 1G8

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LEAD VENTURES INC.
- **DATE OF NAME CHANGE:** 20181023

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**<br> **Washington, D.C. 20549**<br>**Form 6-K**<br>**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br> UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of March, 2023.

Commission File Number: **333-249081**

**<u>CURALEAF HOLDINGS, INC.</u>**<br> (Exact Name of Registrant as Specified in Charter)<br>**666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8**

**Canada**<br> (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ◻ Form 40-F ⌧

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **CURALEAF HOLDINGS, INC.** | **CURALEAF HOLDINGS, INC.** |
|  |  | (Registrant) | (Registrant) |
| Date: | March 24, 2023 | By: | */s/ Peter Clateman* |
|  |  | Name: | &nbsp;&nbsp;&nbsp;&nbsp;Peter Clateman |
|  |  | Title: | &nbsp;&nbsp;&nbsp;&nbsp;Chief Legal Officer |

---

**<u>EXHIBIT INDEX</u>**

[99.1](tm238789d2_ex99-1.htm) [Press Release dated March 24, 2023](tm238789d2_ex99-1.htm)

## Exhibit 99.1

**Exhibit 99.1**

**Curaleaf Provides Update on 2022 Fourth Quarter and Full-Year Earnings Release and Earnings Call**

New York, NY., March 24, 2023 – <u>Curaleaf Holdings, Inc.</u> (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it will delay its fourth quarter and full year earnings release and conference call, which were originally scheduled for March 28, 2023. Due to the complexities of converting three years of financials from IFRS to U.S. GAAP coinciding with year and quarter-end reporting, and the review of the treatment of various accounting matters, the Company requires additional time to complete its financial statements. The Company expects to file its financial statements within the month of April, no later than the prescribed filing deadline provided for under applicable securities laws. The Company will announce the date of the release of its financial statements and an earnings conference call in a subsequent press release.

**About Curaleaf Holdings**

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 19 states with 147 dispensaries and employs nearly 5,500 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit <u>https://ir.curaleaf.com</u>.

FORWARD-LOOKING STATEMENTS

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performances. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the date of release of the Company's financial statements. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed March 9, 2022, which is available under the Company's SEDAR profile at http://www.sedar.com and EDGAR profile at www.sec.gov, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

**INVESTOR CONTACT**

Curaleaf Holdings, Inc.

Camilo Lyon, Chief Investment Officer

<u>IR@curaleaf.com</u>

**MEDIA CONTACT**

Curaleaf Holdings, Inc.

Jordon Rahmil, Senior Director \| Corporate Communications

<u>media@curaleaf.com</u>